Status:

UNKNOWN

Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients

Lead Sponsor:

French Society of Coloproctology

Collaborating Sponsors:

Société Nationale Française de Gastroentérologie

Conditions:

Anal AIN3

Anal Carcinoma

Eligibility:

All Genders

18+ years

Brief Summary

Evaluation of the 3-years anal carcinoma (AC) incidence in patient with anal AIN3 lesions, and factors associated with this AC. A retrospective cohort study will be conducted (2000-2013) followed by a...

Detailed Description

"Background : Incidence of anal carcinoma (AC) is considerably increasing, but no data on risk of AC in patient with anal AIN3 lesions are available, nor french recommendations about screening and tre...

Eligibility Criteria

Inclusion

  • To be included in the cohort, patients have to:
  • \- have an anal AIN3 (including Bowen's disease) diagnosed by histology (screening population, post-operative discovery…)
  • Aposteriori for patients with a history of anal AIN3 complicated or not by an anal cancer. These cases will be identified from data bases of anatomopathology laboratories in hospitals since January 1st 2000.
  • At the diagnostic for the new anal AIN3 Units care involved in the study are those involved in the follow-up of patients with anal pathologies en France, especially anal cancer. Samples are analyzed by the laboratories of anatomopathology of the hospitals where the patients are diagnosed. These points make the histological data bases reliable and allow clearly identifying cases of anal ain3 retrospectively since 2000.
  • Taking in account the number and quality of the units care involved in the study and the way cases are identified, we think our recruitment will be exhaustive in France, to limit selection bias.
  • \- Patient's non opposition to study

Exclusion

  • history of anal carcinoma without any history of anal AIN3 lesion
  • impossible follow-up for the duration of the study (3 years or more)
  • patient aged under 18

Key Trial Info

Start Date :

August 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2019

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT01877135

Start Date

August 1 2013

End Date

June 1 2019

Last Update

March 5 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Service d'Hépato-gastro-entérologie, Hôpital Bichat, 46 rue Henri Huchard

Paris, Paris, France, 75018